However, Myr (300 mg/kg) treatment reversed glycosylated-hemoglobin (p < 0.05), LDH (p < 0.05), CK (p < 0.01), urea (p < 0.01), uric acid (p < 0.01), creatinine (p < 0.01), C-reactive protein (p < 0.01), and AGEs (p < 0.05) levels in the sera of T2D rats as compared to T2D control animals (Table 1). The gene discussed is CRP; the disease is type 2 diabetes mellitus.